HQL 79 |
رقم الكتالوجGC10564 |
HQL 79 ، مثبط قوي ، انتقائي وفعال عن طريق الفم للبروستاغلاندين D سينثاز (H-PGDS) ، يمنع بشكل انتقائي تخليق PGD2 ، ويعمل كعامل مضاد للحساسية ، مع Kd 0.8 ميكرومتر و IC50 من 6 ميكرومتر.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 162641-16-9
Sample solution is provided at 25 µL, 10mM.
HQL-79 is a potent, selective and orally active human hematopoietic prostaglandin D synthase (H-PGDS) inhibitor, highly selectively inhibits the synthesis of PGD2, and acts as an anti-allergic agent, with a Kd of 0.8 μM and an IC50 of 6 μM. Shows no obvious effect on COX-1, COX-2, m-PGES, or L-PGDS[1].
HQL-79 is a competitive inhibitor against substrate PGH2 and a non-competitive one against GSH[1].
References:
[1]. Aritake K, et al. Structural and functional characterization of HQL-79, an orally selective inhibitor of human hematopoietic prostaglandin D synthase. J Biol Chem. 2006 Jun 2;281(22):15277-86. Epub 2006 Mar 17.
Average Rating: 5
(Based on Reviews and 17 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *